Ladostigil | Interleukin Related interleukin-related.com

Product Name :
Ladostigil

Search keywords :
Ladostigil

drugId :
null

Target Vo:
Monoamine oxidase A

Target Vo Short Name :
MAOA

Moa_Name:
Monoamine oxidase B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Teva

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alzheimer Disease

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
His Tag Antibody (HRP) (YA877) web
Figitumumab Autophagy
AHR Antibody: Aryl hydrocarbon Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to Aryl hydrocarbon Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts